Horizon Pharma, Inc.
2 additional investors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 4
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
- Mar 2, 2012Form D equity offering · $65.9M (form d sold)Scale Venture Partners via Louis Craig BockFact Form D · “Horizon Pharma, Inc. Form D, first filed 2012-03-19”
- Feb 22, 2012Form D equity offering · $32,772 (form d sold)Scale Venture Partners via Louis Craig BockFact Form D · “Horizon Pharma, Inc. Form D, first filed 2012-03-08”
- Jun 2, 2011Form D equity offering · $637,500 (form d sold)Scale Venture Partners via Louis Craig BockFact Form D · “Horizon Pharma, Inc. Form D, first filed 2011-06-17”
- Apr 1, 2010Form D equity offering · $20.0M (form d sold)Fact Form D
Investors on record
- Scale Venture Partners form d related, Louis Craig Bock (strongly supported) Inference sec.gov
- Scale Venture Partners form d related, Louis Craig Bock (strongly supported) Inference sec.gov
- Scale Venture Partners form d related, Louis Craig Bock (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.